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Abstract
Background: The disproportion between the large organ demand and the low number of transplantations
performed represents a serious public health problem worldwide. Reducing the loss of transplantable organs from
deceased potential donors as a function of cardiac arrest (CA) may contribute to an increase in organ donations.
Our purpose was to test the hypothesis that a goal-directed protocol to guide the management of deceased
donors may reduce the losses of potential brain-dead donors (PBDDs) due to CA.
Methods: The quality improvement project included 27 hospitals that reported deceased donors prospectively to
the Transplant Center of the State of Santa Catarina, Brazil. All deceased donors reported prospectively between
May 2012 and April 2014 were analyzed. Hospitals were encouraged to use the VIP approach checklist during the
management of PBDDs. The checklist was composed of the following goals: protocol duration 12–24 hours,
temperature > 35 °C, mean arterial pressure ≥ 65 mmHg, diuresis 1–4 ml/kg/h, corticosteroids, vasopressin, tidal
volume 6–8 ml/kg, positive end-expiratory pressure 8–10 cmH2O, sodium < 150 mEq/L, and glycemia < 180 mg/dl.
A logistic regression model was used to identify predictors of CA.
Results: There were 726 PBDD notifications, of which 324 (44.6) were actual donors, 141 (19.4 %) CAs, 226 (31.1 %)
family refusals, and 35 (4.8 %) contraindications. Factors associated with CA reduction included use of the checklist
(odds ratio (OR) 0.43, p < 0.001), maintenance performed inside the ICU (OR 0.49, p = 0.013), and vasopressin
administration (OR 0.56, p = 0.04). More than three interventions had association with less CAs (OR 0.19, p < 0.001).
After 24 months, CAs decreased from 27.3 % to 14.6 % (p = 0.002), reaching 12.1 % in the following two 4-month
periods (p < 0.001). Simultaneous increases in organ recovered per donor and in actual donors were observed.
Conclusions: A quality improvement program based on education and the use of a goal checklist for the
management of potential donors inside the ICU is strongly associated with a decrease in donor losses and an
increase in organs recovered per donor.
Keywords: Organ donor, Organ transplantation, Donor management, Donor management goals, Checklist
* Correspondence: glauco.w@brturbo.com.br
1Central de Transplantes do Estado de Santa Catarina, Florianópolis, Santa
Catarina, Brazil
2Universidade da Região de Joinville, Joinville, Santa Catarina, Brazil
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Westphal et al. Critical Care  (2016) 20:323 
DOI 10.1186/s13054-016-1484-1
Background
The most realistic option to mitigate the imbalance be-
tween the high demand for organ transplantations and
the low number of transplantations performed is to
maximize the use of organs from brain death (BD) do-
nors [1]. This maximization depends on reducing the
underreporting of BD, family refusals, incorrect contra-
indications, and potential brain-dead donor (PBDD) loss
after cardiac arrest (CA) [1–3].
Many donors are lost because they are not properly
managed during the first 24 hours [1]. This shortfall
highlights the importance of the proactive contribution
of intensive care professionals to mitigate the imbalance
between supply and demand of organs for transplant-
ation [1, 4].
In 2011, a joint action of the Brazilian Association of
Critical Care Medicine and the Brazilian Association of
Organ Transplantation resulted in the preparation of the
Brazilian Guidelines for Potential Multiple Organ
Donors. The initiative aimed to provide parameters of
standard care for PBDDs and to reduce loss of donors
because of management failures [5, 6]. Guidelines usu-
ally fail to achieve rapid impacts on bedside manner
changes and rarely consider their practical applicability
[7], and the large-scale transformation of the best scien-
tific evidence into clinical practice is a challenge that
may take years [5]. The establishment of protocols may
help reduce this time, and the management of the
process guided by checklists may play a key role in enab-
ling “real-time route corrections” [8]. The Surviving
Sepsis Campaign experience is a practical example of the
large-scale adoption of a multifaceted model driven by
treatment goals [7]. Its positive effects on outcomes re-
sult from organizational adjustments which could be
adapted to the context of potential organ donor manage-
ment without requiring additional resources.
Meeting care goals in PBDD management designed to
restore the respiratory, cardiovascular, and endocrine-
metabolic physiology during the period preceding organ
harvesting is associated with an increased number of or-
gans transplanted per donor [1, 9–13] and reduced loss
of donors by CA [1, 14].
In a pilot study we reported the association between
the managed BD protocol guided by a goal checklist
and the decrease in CAs among PBDDs [14]. Recog-
nizing both the challenge and the importance of re-
producing those results on a large scale, we conducted
a multicenter program to improve the standard of care
for PBDDs. The BD protocols were guided by an adap-
tation of the classical “VIP” approach, a mnemonic
method proposed by Max Weil and Herbert Shubin to
systematize and simplify a sequence of fundamental
principles for the management of shock as “Ventilation,
Infusion, and Pumping”. The post scriptum “PS” has
been added to refer to “Pharmacological support and
some Specificities”, composing the acronym VIPPS
[15, 16].
Our purpose is to describe a quality improvement pro-
ject that includes the implementation of a checklist
based on the VIP approach for the management of po-
tential multiple organ donors and to analyze its impact
on the occurrence of CA.
Methods
Study design
This is a quality improvement project with prospective
data collection in 27 hospitals that reported deceased
donors to the Transplant Center of the State of Santa
Catarina, Brazil, over six 4-month periods from May
2012 to April 2014. The hospitals were encouraged to
use a goal checklist for the management of PBDDs.
Design of the goal checklist for case management
The main recommendations from the Brazilian Guidelines
for Potential Multiple Organ Donors [5, 6] were pooled to
create a goal checklist based on the adapted form of the
VIP approach (Additional file 1) [15, 16], to achieve nine
goals to be met upon protocol completion: (1) adequate
mechanical ventilation (tidal volume ranging from 6 to
8 ml/kg predicted weight + positive end-expiratory
pressure (PEEP) ranging from 8 to 10 cmH2O + plateau
pressure < 30 cmH2O) and FiO2 titration to obtain
SaO2 > 90 %; (2) mean arterial pressure (MAP) ≥
65 mmHg; (3) diuresis ranging from 1 to 4 ml/kg/h; (4)
temperature ≥ 35 °C upon protocol completion; (5)
vasopressin when a vasoconstrictor is required; (6) cor-
ticosteroids; (7) blood glucose < 180 mg/dl; (8) serum
sodium < 150 mEq/L; and (9) protocol duration ranging
from 12 to 24 hours.
The compliance with the items was supervised by
inhospital transplant coordinators, who alerted the care
team if any noncompliance was observed.
Hospital selection
All hospitals that reported deceased donors to the
Transplantation Center were selected. The eight hospi-
tals with the highest numbers of BD notifications (60 %
of actual organ donations) were selected to perform
onsite training of inhospital transplant coordinators and
ICU teams. The training of teams from the other hospi-
tals was restricted to biannual meetings of transplant co-
ordinators. The hospitals were classified according to
characteristics that may affect performance.
Educational material and implementation and training
meetings
The main recommendations from the Guidelines, the
management checklist and case management
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instructions, were introduced to all inhospital trans-
plant coordinators of the state in April 2012. Extensive
material on the Guidelines and the checklist was pro-
vided on a website. A brief version of the Guidelines
was handed out at face-to-face meetings with the
inhospital transplant coordinators.
A training team consisting of intensivists and nurses
conducted onsite training in the hospitals with the best
notification and donation performances. Intensivists and
nurses were available for consultation by telephone to
the care teams.
Partial data on institutional and state transplant sys-
tem performance were disclosed and discussed every
6 months during the regular meetings of the inhospital
transplant coordinators.
Study population
All patients diagnosed with BD, older than 14 years of
age, prospectively and consecutively notified during the
observation period were included. The diagnosis of BD
was established pursuant to Resolution No. 1480/97 of
the Federal Council of Medicine. Additionally, patients
were characterized as PBDDs at the time that the diag-
nostic investigation for BD was started [17]. Given that
the maintenance protocol is always stopped in cases of
family refusal or clinical contraindication for organ do-
nation after BD confirmation, cases of family decline
and clinical contraindications were excluded from the
analysis. Cases with insufficient information to conduct
the data analysis were also excluded.
Variables analyzed
The following variables were analyzed:
 Hospital characteristics: number of inpatient beds,
number of ICU beds, status as a teaching hospital,
status as a trauma care referral center, existence of a
transplant center, existence of a transplant
coordination unit connected to the ICU, and type of
hospital administration (public or private).
 Characteristics of potential donors: gender, age,
Sequential Organ Failure Assessment (SOFA) score,
organ dysfunctions and number of organ
dysfunctions at the start of BD investigation
(neurological dysfunction was not considered), cause
of BD, presence of infection, and clinical
management site defined as inside the ICU or
outside the ICU (emergency room or postanesthesia
recovery unit).
 Variables related to the checklist: compliance with
the checklist was considered to indicate bedside use,
regardless of the number of interventions met;
compliance with each target was considered when
the goal was effectively reached.
 Outcome variables: the primary outcome variable
was the occurrence of CA, and the following
variables related to the donation process were also
evaluated: actual donations, mean number of organs
retrieved per donor (ORPD), and donor loss because
of family refusal or medical contraindication. The
outcome variables were evaluated at 4-month
intervals during the 2 years of observation and were
compared with the results recorded in the previous
2 years, which served as the baseline for the indicators.
The outcomes from the two 4-month periods following
the observation period were also analyzed to evaluate
performance consistency. Finally, to assess the impact
of this improvement program in the real world, we
assessed data from the annual reports of the Transplant
Center of Santa Catarina between 2011 (year before
the program) and 2014 (year of program completion).
Data collection and treatment
The data collected were transferred to a spreadsheet for
subsequent analysis. For categorical variables, inconsist-
encies and blank data were interpreted as protocol non-
compliance or breach. Blank data or inconsistencies in
the case of continuous variables were disregarded for
analysis. The data were analyzed as follows (Fig. 1):
 Hospital characteristics and their relationship with
CA from the donation process (Fig. 1, analysis A).
 Characteristics of PBDDs and their relationship with
the outcome from the donation process (Fig. 1,
analysis B).
 Compliance with the checklist and its relationship
with CA (Fig. 1, analysis C).
 Relationship of each checklist component with the
occurrence of CA (Fig. 1, analysis D).
 Compliance with the checklist and its association
with CA over time (Fig. 1, analysis E).
Statistical analysis
Statistical analysis was performed using Statistical Package
for the Social Sciences, version 17.0 software (SPSS Inc.,
Chicago, IL, USA). Continuous variables were expressed
as the means ± standard deviations. The Kolmogorov–
Smirnov test was applied to assess the normal distribution
of data. We used Student’s t test to compare means, and
used the nonparametric Mann–Whitney test to compare
the means of nonhomogeneous variances. Categorical var-
iables were expressed as absolute and relative values and
were compared using the chi-squared test. p < 0.05 was
considered statistically significant.
The odds ratio (OR) and 95 % confidence interval (CI)
were determined to evaluate the impact of checklist in-
terventions on the loss of PBDDs from CA. The vari-
ables of interest were selected from this analysis to
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construct two models of multivariate prediction by logis-
tic regression, considering the occurrence of CAs the
dependent variable: a global model—hospital, potential
donor, and clinical management procedure characteris-
tics; and a checklist model—restricted to PBDDs to
whom the goal checklist was applied. All variables for
which a significant level of p < 0.10 was obtained in the
univariate model were introduced into the models.
Results
A total of 767 BD notifications occurred over six 4-
month periods. Of these, 41 cases were excluded, and
the other 726 PBDDs were distributed as follows: 324
(44.6 %) actual donors, 141 (19.4 %) CAs, 226 (31.1 %)
family refusals, and 35 (4.8 %) contraindications (Fig. 1).
Hospital characteristics and CA risk
The eight hospitals that received onsite training
accounted for 54.9 % of the PBDDs. Hospitals with more
than 250 beds, with an active organ transplant center,
and with an inhospital transplant coordination unit con-
nected to the ICU were associated with a reduced occur-
rence of CAs. Public hospitals and hospitals with fewer
than 150 beds had a higher number of losses of PBDDs
during management (Table 1).
Potential donor characteristics and CA risk
The clinical and demographic characteristics of the 465
PBDDs analyzed are outlined in Table 2. The odds of
CA was higher among PBDDs aged > 60 years and when
clinical management was performed outside the ICU,
and increased in proportion to the number of organ dys-
functions observed at the start of BD investigation. The
SOFA scores at the start of the BD investigation were
similar between actual donors and those who experi-
enced CA (4.9 ± 2.2 vs 5.1 ± 2.3, p = 0.71).
Compliance with the checklist and its components
Table 3 shows that use of the checklist was associated
with lower odds of occurrence of CA (OR 0.30, 95 % CI
0.18; 0.49, p < 0.001). The frequency of CAs decreased as
the number of checklist items complied with increased,
and the odds of those losses were substantially lower
upon compliance with four or more checklist interven-
tion items (OR 0.19, 95 % CI 0.11; 0.34, p < 0.001). Full
compliance with the nine checklist interventions was
not observed; the maximum performance levels met
seven items in only nine patients.
Of 465 PBDDs, 83 were not managed with the check-
list. Potential donors managed without the checklist
were more frequent in the first quarter (n = 31, 37.5 %)
and were then evenly distributed throughout the study
period (10.2 ± 2.5 per quarter). Both groups (with and
without checklist) were similar to each other regarding
clinical and demographic characteristics and the following
treatment goals: donor maintenance, duration ranging
from 12 to 24 hours, temperature > 35 °C upon protocol
completion, diuresis ranging from 1 to 4 ml/kg/h, serum
sodium < 150 mEq/L, blood glucose < 180 mg/dl, and the
number of organs donated/donor (with checklist: 2.0 ± 0.5
organs vs without checklist: 2.1 ± 0.3 organs, p < 0.83). In
contrast, the use of corticosteroids (p < 0.001), vasopressin
(p < 0.001), adequate ventilation (p < 0.001), and MAP
levels upon management completion (73 ± 44 mmHg vs
63 ± 44 mmHg, p < 0.05) were higher when the manage-
ment checklist was applied.
Fig. 1 Study flowchart. Shaded boxes show the different analyses in the study. CI contraindications
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The following treatment goals were associated with re-
duced risk of CA among the 382 PBDDs to whom the
checklist was applied: temperature ≥ 35 °C (p = 0.001),
MAP ≥ 65 mmHg (p < 0.001), corticosteroid administra-
tion (p = 0.006), vasopressin administration to PBDDs
using vasoconstrictors (p = 0.042), and protocol duration
ranging from 12 to 24 hours (p = 0.07) (Table 4).
Multivariate analysis and the occurrence of CA
A global model of multivariate analysis was designed
based on the hospital and potential donor characteristics
and the clinical management goals that were associated
with the occurrence of CAs (Table 5). The variables
associated with decreased CAs were a hospital with
more than 250 beds, performing organ transplants, man-
agement of PBDDs performed in the ICU, and use of the
management checklist. Public hospitals, accounting for
81.5 % of the hospitals in the system, were associated
with higher odds of occurrence of CAs.
Based on the findings presented in Table 4 we performed
a multivariate analysis model restricted to the 382 PBDDs
to whom the checklist was applied to assess the individual
effects of checklist components on CAs (Table 5). The var-
iables best associated with decreased CAs were the admin-
istration of vasopressin for donors using vasoconstrictors
and MAP ≥65 mmHg upon protocol completion.
Compliance with the checklist and its association with
CAs and ORPD over time
Increased compliance with the checklist occurred be-
tween the first and second 4-month periods (52.1 % vs
85.8 %, p < 0.001), with rates around 80 % maintained
until the end of the study (Fig. 2a).
Family refusals and contraindications remained constant
throughout the intervention period (Fig. 2b). The compari-
son between the two study years and the performance of
the state transplant system in the two previous years
(CA: 27.3 %) showed downward trends in CAs in the
second (20.6 %, p = 0.08) and third (19 %, p = 0.09) 4-
month periods. After 24 months, CAs decreased to
14.6 % (p = 0.002), reaching 12.1 % in the following two
4-month periods (p < 0.001). Simultaneously, increases
in actual donations were observed (Fig. 2c). At the
baseline, the mean number of ORPD was 2.54 ± 1.08,
which increased to 2.78 ± 1.03 ORPD (p = 0.11) after
24 months and to 2.90 ± 0.93 ORPD (p < 0.004) in the
following two 4-month periods.
The analysis of the annual records of the Transplant
Center of Santa Catarina showed the following rates for
2011 and 2014 respectively: BD notifications, 61.5 per
million population (pmp) and 75.1 % (p = 0.003); family
refusal, 37 % and 38.5 % (p = 0.21); clinical contraindica-
tions, 5.2 % and 11.9 % (p < 0.001); CAs, 27.1 % and
13 % (p < 0.001); and effective donations, 25.4 pmp and
32.3 pmp (p = 0.02). The mean number of ORPD also in-
creased in this period (2011: 2.61 ± 0.82; 2014: 2.99 ±
0.96, p < 0.001).
Discussion
Using the VIP approach checklist reduced the odds of
CA in PBDDs prior to organ harvesting 2.3-fold, in-
creasing actual multiple organ donations over time. The
number of CAs was inversely proportional to the num-
ber of treatment goals met. Hence, the VIP approach
seems to be useful to increase awareness of physicians to
guarantee a “standard of care” during the management
of PBDDs. To our knowledge, this is the first
Table 1 Hospital characteristics and their relationship with






p value OR (95 % CI)
Total, n (%) 27 (100) 141/465 (30.3)
Hospital beds, n (%)
< 150 beds 10 (37.0) 29/62 (46.7) 0.002 2.28 (1.32; 3.93)
150–250 beds 10 (37.0) 65/217 (29.9) 0.87
> 250 beds 7 (25.9) 47/186 (25.2) 0.053 0.66 (0.44; 1.0)
ICU beds, n (%)
< 5 % 5 (18.5) 44/131 (33.5) 0.33
5–10 % 15 (55.6) 89/294 (30.3) 0.97
> 10 % 7 (25.9) 14/39 (35.8) 0.43
Teaching, n (%)
Yes 15 (55.6) 101/329 (30.7) 0.78
No 12 (44.4) 40/136 (29.4)
Trauma referral center, n (%)
Yes 15 (55.6) 112/354 (31.6) 0.27
No 12 (44.4) 29/111 (26.1)
Transplant center, n (%)
Yes 6 (22.2) 44/211 (20.8) <0.001 0.42 (0.28; 0.65)
No 21 (78.8) 97/254 (38.1)
Onsite training, n (%)
Yes 8 (29.7) 69/238 (28.9) 0.52
No 19 (70.3) 72/227 (31.7)
Transplant coordination unit connected to the ICU, n (%)
Yes 17 (63.0) 113/394 (18.2) 0.07 0.61 (0.36; 1.04)
No 10 (37.0) 28/70 (25.9)
Public administration, n (%)
Yes 22 (81.5) 137/433 (31.6) 0.02 3.23 (1.11; 9.41)
No 5 (18.5) 4/31 (12.3)
For variables with more than two categories, each category was compared
with the sum of the others
OR odds ratio, CI confidence interval
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multicenter report providing evidence of benefits from a
management protocol of potential organ donors guided
by a goal checklist in a developing country.
This program for improvement of BD donor manage-
ment had the characteristics of a task force for dissem-
ination and application of evidence-based clinical
practice guidelines of PBDD management endorsed by
the national associations of critical care and transplant-
ation [5, 6]. The main recommendations from the
Guidelines were organized into a goal checklist used to
guide case management. Our local experience with a
management protocol enabled establishing a strong as-
sociation between attaining a set of goals organized
into bundles and decreasing CAs among PBDDs [14].
The prospect of broadening the results from that pilot
study prompted this regionwide program to improve
the management of PBDDs. Inspired by the Surviving
Sepsis Campaign, this donor management optimization
initiative consisted of an institutional process of per-
formance improvement which, according to its own
characteristics, does not meet all scientific rigor re-
quired to assess the impact of the best evidence on
clinical outcomes [10].
From our perspective, the VIP approach checklist is an
alternative to the existing donor optimization care bun-
dles, proposing an adaptation of a classic strategy for the
management of the circulatory shock [16]. The VIP ap-
proach provides a simple sequence of procedures intrin-
sically directed to the restoration of DO2 and shock
control, which is present in 80 % of PBDDs and is the
leading cause of CA in these individuals [15].
Despite the positive impact of our checklist on CA, a
rate of 12.1 % of CAs may sound high for some. In this
Table 2 Potential donor characteristics (excluding









p value OR (95 % CI)
Gender, n (%)
Male 279 85 (30.5) 0.93
Female 186 56 (30.1)
Age group, n (%)
< 20 years 38 10 (26.3) 0.57
21–40 years 105 27 (25.7) 0.24
41–60 years 207 58 (28.0) 0.33
> 60 years 115 46 (40.0) 0.009 1.79 (1.15; 2.78)
Cause of BD, n (%)
Traumatic brain injury
165 52 (30.9) 0.84
Hemorrhagic stroke 161 50 (31.1) 0.80
Ischemic stroke 56 14 (25.0) 0.35
Subarachnoid
hemorrhage
34 10 (29.4) 0.90
Hypoxic
encephalopathy
38 10 (26.3) 0.57
Other 11 5 (45.5) 0.27
Organ dysfunction, n (%)
Cardiovascular 297 85 (28.6) 0.46
Pulmonary 147 44 (29.9) 0.96
Renal 120 43 (35.8) 0.13
Hepatic 39 11 (28.2) 0.79
Hematologic 118 34 (28.8) 0.74
Number of organ dysfunctions at the start of BD investigation, n (%)
0–1 230 55 (13.9) 1 (Referencea)
2 136 43 (31.6) 0.03 1.66 (1.03; 2.68)
3 70 27 (38.0) 0.004 2.26 (1.27; 4.01)
≥4 29 16 (55.2) 0.002 4.43 (1.99; 9.82)
Infection, n (%)
Yes 322 96 (29.8) 0.72
No 143 45 (31.5)
Clinical management site, n (%)
ICU 369 103 (27.9) 0.02 0.59 (0.37; 0.94)
Outside the ICU 96 38 (39.6)
aWe used potential donors with zero and one dysfunction as a reference to
test the effect of the number of organ dysfunctions at the start of the BD
investigation of cardiac arrests. For the other variables with more than two
categories, each category was compared with the sum of the others
BD brain death, OR odds ratio, CI confidence interval
Table 3 Risk of occurrence of cardiac arrest according to
compliance with the checklist for potential organ donor
management
Intervention and population N Cardiac
arrests
OR (95 % CI) p value
Without checklist 83 44 (53.0) 1 (Referencea)
With checklist 382 97 (25.4) 0.30 (0.18; 0.49) <0.001
Number of interventions, n (%)a
1 60 21 (35.0) 0.47 (0.24; 0.94) 0.033
2 23 11 (47.8) 0.81 (0.32; 2.05) 0.65
3 62 22 (38.7) 0.48 (0.24; 0.96) 0.036
4 102 21 (20.6) 0.23 (0.12; 0.44) <0.001
5 85 16 (18.8) 0.20 (0.10; 0.41) <0.001
6 and 7 50 6 (12.0) 0.12 (0.04; 0.31) <0.001
8 and 9 0 0
Set of interventions, n (%)
1–3 items 145 54 (37.2) 0.52 (0.30; 0.90) 0.02
≥ 4 items 237 43 (18.1) 0.19 (0.11; 0.34) 0.001
aReference: potential donors to whom the checklist was not applied
OR odds ratio, CI confidence interval
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context, it is important to consider that the incidence of
CA reported in our results accounts for all events that
occurred after starting the first BD diagnostic test, which
will result in a necessarily larger number of CAs than
those presented in countries which take into account
only the CAs that occurred in consented PBDDs.
The annual records of the Transplant Center show
that the reduction of losses of donors by CA (2011:
27.1 % to 2014: 13 %, p = 0.002) strongly contributes to
increasing the effective donations in the state of Santa
Catarina (32.3 pmp), which is already close to rates re-
ported by the best world performances of Spain and
Croatia (35 pmp), and even higher than Portugal (28.3
pmp) or the United States (25.9 pmp) [18]. Moreover, it
was possible to observe an additional effect of the clin-
ical optimization provided by the VIP approach, which
not only reduced the number of unexpected CAs, but
also increased the suitability of organs.
Our results are consistent with some reports pre-
sented earlier. Salim et al. [1] showed that an aggres-
sive strategy of deceased potential donor management
reduced the loss of organ donors due to CA by 87 %
(p < 0.001) and increased the number of organ donors
by 82 % (p < 0.001) over 8 years. A series of publica-
tions from the Organ Procurement Organizations
(OPOs) of the United Network for Organ Sharing
(UNOS) has shown that standardization of procedures
of PBDD management towards meeting clinical goals
can increase the number of donors and the number of
organs transplanted per donor [9–14, 19, 20].
The fact that public hospitals had an increased associ-
ation with the risk of CAs may be partly explained by in-
frastructure problems, including the availability of ICU
beds. There was a high number of PBDDs (20.6 %) man-
aged outside the ICU, where the treatment conditions
may be suboptimal. Although our study was conducted
in one of the most developed regions of the country,
with a number of ICU beds similar to that of USA and
many European countries, we have to consider the local
heterogeneity of health care resources. There are differ-
ences in infrastructure between public and private
Table 4 Risk of occurrence of cardiac arrest among patients to
whom the donor management checklist was applied according




Total, n = 382 Cardiac arrests,
n = 97 (25.4 %)
OR (95 % CI) p value
Duration of protocol 12–24 h, n (%) (all)
Yes 101 (26.4) 19 (18.1) 0.60 (0.34; 1.06) 0.07
No 281 (73.6) 78 (27.7)
Temperature > 35 ° C, n (%) (all)
Yes 283 (74.1) 60 (21.2) 0.48 (0.27; 0.74) 0.001
No 99 (25.9) 37 (37.3)
MAP > 65 mmHg, n (%) (all)
Yes 285 (74.6) 60 (21.1) 0.43 (0.26; 0.71) <0.001
No 97 (25.4) 37 (38.1)
Diuresis from 1 to 4 ml/kg/h, n (%) (all)
Yes 210 (54.9) 49 (23.3) 0.78 (0.49; 1.24) 0.30
No 172 (45.1) 48 (27.9)
Corticosteroids, n (%) (all)
Yes 263 (68.8) 56 (21.3) 0.51 (0.32; 0.83) 0.006
No 119 (31.2) 41 (34.4)
Vasopressin, n (%) (vasoconstrictor use, n = 236)
Yes 41(17.4) 5 (12.2) 0.37 (0.13; 0.99) 0.042
No 195 (82.6) 53 (27.1)
Mechanical ventilation, n (%) (all)
Yes 256 (67.1) 61 (23.8) 0.78 (0.48; 1.27) 0.32
No 126 (32.9) 36 (28.6)
Sodium < 150 mEq/L, n (%) (all)
Yes 142 (37.2) 36 (25.4) 0.99 (0.61; 1.60) 0.99
No 240 (62.8) 61 (25.5)
Blood glucose < 180 mg/dl, n (%) (all)
Yes 151 (39.5) 39 (25.8) 1.03 (0.64; 1.66) 0.87
No 231 (60.5) 58 (25.1)
OR odds ratio, CI confidence interval, MAP mean arterial pressure
Table 5 Multivariate analysis for cardiac arrest prediction in
potential brain dead donors
Variable OR (95 % CI) p value
Global analysis (n = 465)
Hospital characteristics
>250 beds 0.59 (0.36; 0.98) 0.04
Organ procurement staff linked to the ICU 0.58 (0.74; 3.41) 0.23
Public hospital 9.25 (2.07; 41.1) 0.003
Active transplant program 0.36 (0.21; 0.60) <0,001
Potential donors characteristics
> 60 years old 1.57 (0.96; 2.57) 0.07
≥ 2 organ dysfunctions 1.48 (0.69; 2.13) 0.16
Management characteristics
Clinical care provided inside the ICU 0.49 (0.28; 0.86) 0.013
Checklist use 0.43 (0.20; 0.62) <0.001
Checklist analysis (n = 382)
Duration of the protocol 12–24 h 0.65 (0.39; 1.15) 0.16
Temperature≥ 35 ° C 0.68 (0.34; 1.36) 0.28
Mean arterial pressure≥ 65 mmHg 0.54 (0.26; 1.03) 0.055
Corticoids 0.67 (0.39; 1.15) 0.15
Vasopressin 0.56 (0.32; 0.97) 0.04
OR odds ratio, CI confidence interval
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hospitals and even among public hospitals, depending
on the degree of complexity of each institution [21, 22].
Furthermore, donor losses due to CA in public institu-
tions were mitigated in hospitals with more than 250
beds and in those performing transplantations (Table 5),
which are also indicative of better infrastructure and
organizational conditions.
The odds of CA have been higher among PBDDs >
60 years old and those with more organ dysfunction at
baseline. However, these variables did not stand out as
CA predictors in the multivariate analysis. Considering
the nearly absolute vasopressin deficiency that occurs in
the first minutes after BD [23, 24], early replacement of
this hormone has been formally recommended for the
80 % of PBDDs needing vasopressors [5, 6, 25–27].
Vasopressin replacement is independently associated
with an increased rate of organ recovery and a less over-
all graft rejection due to poor function [28]. The good
pressure control related to vasopressin administration
[24] corroborates the association of vasopressin use and
obtaining MAP ≥ 65 mmHg with the decrease in CAs
observed in our results. However, meeting isolated goals
such as MAP ≥ 65 mmHg may not suffice to prevent CA
among PBDDs [10]. This point is reinforced by the ob-
servation that the decrease in the number of CAs was
more consistent when a greater number of interventions
were used in combination (Table 3), reflecting the qual-
ity of care provided.
Despite the good compliance with the checklist already
observed in the first months, donor loss due to CA de-
creased slowly over time (Fig. 2). The prioritization of
hospitals with a history of a high number of organ do-
nors, the slower recruitment of lower-performance hos-
pitals, and the learning curve of care teams may explain
this delay. Additionally, even with an active education
program, the incorporation of new evidence and guide-
line recommendations may take years and usually fail to
achieve rapid impacts at the bedside.
It could be seen as negative that a checklist is needed
to do what should be done, but it is known that health
Fig. 2 Changes in (a) adherence to checklist (%), (b) family decline (%) and contraindications (%), and (c) CAs (%) and actual donors (%) over time. Shaded
area refers to 2 years of data collection divided into 4-month periods. White Areas refer to the previous 2 years and the two subsequent quarters of the
observation period. *p< 0.01 and **p< 0.05 related to first 4-month period. #p< 0.01 and ##p< 0.05 compared with previous 2 years of the study period
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care centralized on the physician may result in noncom-
pliance with guideline recommendations, especially in
highly complex processes such as the management of
donors [29]. In contrast, there are many demonstrations
that the systematic use of multidisciplinary checklists as
alert devices for the physician improves the process of
care, decreasing catheter-related bloodstream infections
[30, 31], surgical-related morbidity and mortality [32],
and clinical outcomes in the ICU [33]. It is also known
that the mere existence of a checklist does not ensure its
effective application, highlighting the importance of
managing the bedside protocol, wherein a case manager
advises the care team [34]. In the context of PBDD man-
agement, inhospital transplantation coordinators should
be encouraged to play the leading role of case managers,
alerting the care team based on a goal checklist.
Our study has some limitations. First, the observa-
tional nature of this study only allows us to infer associ-
ations between the use of the checklist and the decrease
in the loss of donors due to CA. Second, the data on
therapeutic interventions performed on PBDDs to whom
the checklist was not applied are not entirely reliable be-
cause these data were derived from secondary records.
Third, we did not evaluate the quality of the organs do-
nated or graft function and survival, which limited the
scope of the analysis of the effects of interventions.
Fourth, regional factors that may influence the total time
of the PBDD maintenance process and therefore the oc-
currence of CA in PBDDs must be considered, such as
the differences in BD diagnosis methodologies.
The overlap of medical, administrative, logistical, and
legal aspects during the donation process makes the
management of PBDDs extremely complex, sometimes
stressful, and highly dependent on the involvement of an
organized care team. The use of clinical protocols in this
situation may help as a guidance and alert tool towards
meeting goals. To promote adherence to clinical proto-
cols, three fundamental aspects must be followed: to set
goals based on the best available evidence; to standardize
management; and to simplify the protocol to the max-
imum. In addition, standards of care provide opportun-
ities for future observational studies or randomized trials
that can help to provide new and better evidence on this
subject.
Conclusions
A quality improvement program based on education and
the use of the VIP approach for the bedside management
of PBDDs is strongly associated with a reduction in
donor loss from CA, increasing actual donors and
ORPD. Organ transplant hospitals, clinical management
performed in the ICU, obtaining MAP ≥ 65 mmHg, and
vasopressin use are factors that also mitigate the occur-
rence of CAs. Such a checklist may promote staff
commitment to the quality of care during the manage-
ment of PBDDs.
Key messages
 The management of PBDDs is extremely complex
and depends on the involvement of a highly
organized care team.
 The systematic application of a checklist for the
clinical management of PBDDs is useful to increase
physicians’ awareness and the quality of care.
 The use of clinical protocols during PBDD
management may help the care team as a guidance
and alert tool towards meeting goals.
 Meeting clinical goals during clinical management of
PBDDs leads to a progressive reduction in CAs,
contributing to an increase in actual donors.
 Governmental and/or associative initiatives
promoting coordinated actions of the donation and
transplant process may amplify the effects and
strongly contribute to reducing the imbalance
between the supply and demand of transplant organs.
Additional file
Additional file 1: is Table S1 presenting the sequence of diagnostic
and therapeutic measures applied to the potential organ donor
according to the VIP approach. (DOCX 17 kb)
Abbreviations
BD: Brain death; CA: Cardiac arrest; CI: Confidence interval; DO2: Oxygen
delivery; FiO2: Fraction of inspired oxygen; MAP: Mean arterial pressure;
OPO: Organ Procurement Organization; OR: Odds ratio; ORPD: Organs
retrieved per donor; PBDD: Potential brain-dead donor; PEEP: Positive
end-expiratory pressure; pmp: Per million population; SaO2: Arterial oxygen
saturation; SOFA: Sequential Organ Failure Assessment; UNOS: United
Network for Organ Sharing; VIP: Ventilation, Infusion and Pumping;
VIPPS: Ventilation, Infusion, Pumping, Pharmacological support and
Specificities
Acknowledgements
Special thanks to all intensivists, intensive care nurses, and inhospital
transplant coordinators of Saint Catarina for their efforts to contribute to this
important quality improvement project.
Funding
There was no funding from private or public entities.
Availability of data and materials
The data that support the findings of this study are available from Transplant
Center of Santa Catarina, Brazil. There are some restrictions to the availability
of these data, which were used under license for the current study, and so
are not publicly available. Data will be available from the authors upon
request and with permission from the Transplant Center of Santa Catarina,
Brazil.
Authors’ contributions
GAW was the principal study coordinator, conceived the study, participated
in the statistical analysis, and helped to write all manuscript versions. EC
participated in the study design and supervision of statistical analysis, and
helped to write the final version of the manuscript. RLdS and SW helped in
the coordination of the study and to revise the manuscript. AM, FC, and GT
Westphal et al. Critical Care  (2016) 20:323 Page 9 of 11
conducted the pilot study and the collection and storage of data, as well as
drafting part of the manuscript and performing the preliminary statistical
analysis. SH and TCC participated in the study design, got Institutional
Review Board approval, and revised the final manuscript. MCM coordinated
the pilot study and revised the final manuscript. EB and FB recruited the
patients and edited the later versions of the manuscript. IB and KG recruited
the patients and revised the manuscript. BSdS recruited the patients and
helped to draft the initial versions of the manuscript. MT recruited the
patients, helped in study design, and helped to edit the manuscript. JdA
participated in the study coordination and final manuscript critical revision.
All authors read and approved the manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
The article is original and has not already been published in a journal, and is
not currently under consideration by another journal. All authors authorize
the full publication of this article.
Ethics approval and consent to participate
The study was approved by the institutional Research Ethics Committee of
the Santa Catarina State Secretary of Health under Registration No. 809.297/
2014. Informed consent was not necessary given the observational nature of
the study.
Institution where the work was performed
Central de Notificação, Captação, Doação de Órgãos e Tecidos para
Transplantes do Estado de Santa Catarina (CNCDO/SC), Brazil.
Supporting and partner organizations
Sociedade Catarinense de Terapia Intensiva (SOCATI), Brazil; Associação
Brasileira de Medicina Intensiva (AMIB); Centro Hospitalar Unimed de
Joinville, Brazil; Master Alianza—Organización Nacional de Trasplantes (ONT),
Spain; and Brazilian Research in Intensive Care Network (BRICNet).
Author details
1Central de Transplantes do Estado de Santa Catarina, Florianópolis, Santa
Catarina, Brazil. 2Universidade da Região de Joinville, Joinville, Santa Catarina,
Brazil. 3Organización Nacional de Trasplantes, Madrid, Spain. 4Centro
Hospitalar Unimed de Joinville, Joinville, Santa Catarina, Brazil. 5Hospital
Regional Homero de Miranda Gomes, São José, Santa Catarina, Brazil.
6Hospital São Francisco, Concórdia, Santa Catarina, Brazil. 7Hospital Municipal
São José, Joinville, Santa Catarina, Brazil. 8Hospital Santa Isabel, Blumenau,
Santa Catarina, Brazil. 9Hospital Marieta Konder Bornhausen, Itajaí, Santa
Catarina, Brazil. 10Hospital e Maternidade São José, Jaraguá do Sul, Santa
Catarina, Brazil. 11Rua Doutor Plácido Gomes, 500 Bairro Anita Garibaldi,
89.202-050 Joinville, Santa Catarina, Brazil.
Received: 14 March 2016 Accepted: 13 September 2016
References
1. Salim A, Velmahos GC, Brown C, et al. Aggressive organ donor
management significantly increases the number of organs available for
transplantation. J Trauma. 2005;58(5):991–4.
2. España. Ministerio de Sanidad, Política Social e Igualdad. Organización
Nacional de Trasplantes. Guía de buenas prácticas en el proceso de
ladonación de órganos. España: Organización Nacional de Trasplantes; 2011.
http://www.ont.es/publicaciones/Documents/GUIA_BUENAS_PRACTICAS_
DONACION_ORGANOS.pdf. Accessed 5 Aug 2015.
3. Powner D. Aggressive donor care—to what end? J Intensive Care Med.
2008;23(6):409–11.
4. DuBose J, Salim A. Aggressive organ donor management protocol.
J Intensive Care Med. 2008;23:367–75.
5. Westphal GA, Caldeira Filho M, Vieira KD, et al. Guidelines for potential multiple
organ donors (adult). Part I. Rev Bras Ter Intensiva. 2011;23(3):255–68.
6. Westphal GA, Caldeira Filho M, Fiorelli A, et al. Guidelines for maintenance
of adult patients with brain death and potential for multiple organ
donations: the Task Force of the Brazilian Association of Intensive Medicine
the Brazilian Association of Organs Transplantation, and the Transplantation
Center of Santa Catarina. Transplant Proc. 2012;44(8):2260–7.
7. Levy MM, Dellinger RP, Townsend SR, et al. The Surviving Sepsis Campaign:
results of an international guideline-based performance improvement
program targeting severe sepsis. Intensive Care Med. 2010;36(2):222–31.
8. Titler MG. The evidence for evidence-based practice implementation. In: Hughes
RG, editor. Patient safety and quality: an evidence-based handbook for nurses.
Vol. 1. 6th ed. Rockville: Agency for Healthcare Research and Quality; 2008.
9. Hagan ME, McClean D, Falcone CA, et al. Attaining specific donor
management goals increases number of organs transplanted per donor:
a quality improvement project. Prog Transplant. 2009;19:227–31.
10. Franklin GA, Santos AP, Smith JW. Optimization of donor management
goals yields increased organ use. Am Surg. 2010;76(6):587–94.
11. Malinoski DJ, Daly MC, Patel MS, et al. Achieving donor management goals
before deceased donor procurement is associated with more organs
transplanted per donor. J Trauma. 2011;71(4):990–5.
12. Malinoski DJ, Patel MS, Daly MC, UNOS Region 5 DMG workgroup, et al. The
impact of meeting donor management goals on the number of organs
transplanted per donor: results from the United Network for Organ Sharing
Region 5 prospective donor management goals study. Crit Care Med.
2012;40(10):2773–80.
13. Patel MS, Zatarain J, De La Cruz S, et al. The impact of meeting donor
management goals on the number of organs transplanted per expanded
criteria donor: a prospective study from the UNOS Region 5 Donor
Management Goals Workgroup. JAMA Surg. 2014;149(9):969–75.
14. Westphal GA, Zaclikevis VR, Vieira KD, et al. A managed protocol for
treatment of deceased potential donors reduces the incidence of cardiac
arrest before organ explant. Rev Bras Ter Intensiva. 2012;24(4):334–40.
15. Westphal GA. A simple bedside approach to therapeutic goals achievement
during the management of deceased organ donors—an adapted version of
the “VIP” approach. Clin Transplant. 2016;30(2):138–44. doi:10.1111/ctr.12667.
16. Weil MH, Herbert SH. The "VIP" approach to the bedside management of
shock. JAMA. 1969;207(2):337–40.
17. Brasil. Conselho Federal de Medicina. Critérios diagnósticos de brain death.
Brasília: Resolução CFM N° 1480. 1997. http://www.planalto.gov.br/ccivil_03/
leis/L9434.htm. Accessed 5 Aug 2015.
18 Registro Brasileiro de Transplantes. Dimensionamento dos Transplantes no Brasil
e em cada estado. Ano. 2014;20(4):3–95. Available on line at: http://www.abto.
org.br/abtov03/Upload/file/RBT/2014/rbt2014-lib.pdf. Accessed 25 Sep 2016.
19. Miñambres E, Coll E, Duerto J, et al. Effect of an intensive lung donor-
management protocol on lung transplantation outcomes. J Heart Lung
Transplant. 2014;33(2):178–84.
20. Miñambres E, Pérez-Villares JM, Chico-Fernández M, et al. Lung donor
treatment protocol in brain dead-donors: a multicenter study. J Heart Lung
Transplant. 2015;34(6):773–80.
21. Wunsch H, Angus DC, Harrison DA, Collange O, Fowler R, Hoste EA, de
Keizer NF, Kersten A, Linde-Zwirble WT, Sandiumenge A, Rowan KM.
Variation in critical care services across North America and Western Europe.
Crit Care Med. 2008;36(10):2787–93.
22. Rhodes A, Moreno RP. Intensive care provision: a global problem. Rev Bras
Ter Intensiva. 2012;24(4):322–5.
23. Howlett TA, Keogh AM, Perry L, et al. Anterior and posterior pituitary
function in brain-stem-dead donors. Transplantation. 1989;48:1078–9.
24. Chen EP, Bittner HB, Kendall SW, Van Trigt P. Hormonal and hemodynamic
changes in a validated animal model of brain death. Crit Care Med.
1996;24:1352–9.
25. Chen JM, Cullinane S, Spanier TB, et al. Vasopressin deficiency and pressor
hypersensitivity in hemodynamically unstable organ donors. Circulation.
1999;100:II244–6.
26. Shemie SD, Ross H, Pagliarello J, Baker AJ, Greig PD, Brand T, Cockfield S,
Keshavjee S, Nickerson P, Rao V, Guest C, Young K, Doig C, Pediatric
Recommendations Group. Organ donor management in Canada:
recommendations of the forum on Medical Management to Optimize
Donor Organ Potential. CMAJ. 2006;174(6):S13–32.
27. Kotloff RM, Blosser S, Fulda GJ, et al. Management of the potential organ
donor in the ICU: Society of Critical Care Medicine/American College of
Chest Physicians/Association of Organ Procurement Organizations
Consensus Statement. Crit Care Med. 2015;43:1291–325.
28. Plurad DS, Bricker S, Neville A, Bongard F, Putnam B. Arginine vasopressin
significantly increases the rate of successful organ procurement in potential
donors. Am J Surg. 2012;204(6):856–60.
Westphal et al. Critical Care  (2016) 20:323 Page 10 of 11
29. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR.
Why don't physicians follow clinical practice guidelines? A framework for
improvement. JAMA. 1999;282(15):1458–65.
30. Berenholtz SM, Pronovost PJ, Lipsett PA, et al. Eliminating catheter-related
bloodstream infections in the intensive care unit. Crit Care Med.
2004;32:2014–20.
31. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease
catheter-related bloodstream infections in the ICU. N Engl J Med.
2006;355:2725–32.
32. Haynes AB, Weiser TG, Berry WR, et al. A surgical safety checklist to reduce
morbidity and mortality in a global population. N Engl J Med.
2009;360(5):491–9.
33. Weiss CH, Moazed F, McEvoy CA, et al. Prompting physicians to address a
daily checklist and process of care and clinical outcomes: a single-site study.
Am J Respir Crit Care Med. 2011;184(6):680–6.
34. Todd WE, David N. Disease management: a systems approach to improving
patient outcomes. The six defining aspects. Int J Integr Care. 2002;2:e22.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Westphal et al. Critical Care  (2016) 20:323 Page 11 of 11
